About Fin-Ceramica
Fin-Ceramica Faenza S.p.A. was founded in 1987 as a spin-off of the Institute of Science and Technology for Ceramic Materials of the Italian National Research Council (CNR), and became operational in 1992. The Tampieri Group has owned it fully since 2005. It is based in Faenza, Italy, and has 42 employees.
The company develops hydroxyapatite-based biomaterials for regenerative surgery in cranial, orthopaedic, maxillofacial and spinal surgery. It is certified to ISO 9001 and ISO 13485 and complies with 21 CFR 820; its products have reached 63 countries since 2003.
What Lavender Medical supplies
MaioRegen, a biomimetic, resorbable scaffold of collagen and magnesium-enriched hydroxyapatite for one-step treatment of cartilage and osteochondral lesions of the knee and ankle.
